MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q2 2014. The put-call ratio across all filers is 3.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,488,000 | -65.3% | 146,611 | -60.0% | 0.63% | -61.2% |
| Q4 2015 | $15,810,000 | +10.5% | 366,305 | -4.0% | 1.63% | +22.4% |
| Q3 2015 | $14,309,000 | -2.6% | 381,765 | -11.7% | 1.34% | +19.9% |
| Q2 2015 | $14,696,000 | -8.4% | 432,365 | -4.6% | 1.11% | -3.0% |
| Q1 2015 | $16,038,000 | -22.0% | 453,040 | -24.9% | 1.15% | -14.4% |
| Q4 2014 | $20,549,000 | -15.4% | 603,305 | -4.3% | 1.34% | -0.8% |
| Q3 2014 | $24,303,000 | -3.2% | 630,090 | -2.3% | 1.35% | +3.4% |
| Q2 2014 | $25,110,000 | +2.5% | 645,165 | -10.0% | 1.31% | -2.3% |
| Q1 2014 | $24,497,000 | +55.7% | 716,500 | -4.5% | 1.34% | +48.2% |
| Q4 2013 | $15,737,000 | – | 750,090 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |